BioSpace News Archive

Athletes who have attention deficit hyperactivity disorder (ADHD) may be at greater risk for experiencing persistent anxiety and depression after a concussion than people who do not have ADHD, according to a preliminary study released today that will be presented at the American Academy of Neurology’s Sports Concussion Conference in Indianapolis, July 20 to 22, 2018.

According to data published by Marijuana Business Daily, cannabis retail sales continue to grow year-over-year, as new markets emerge, and more states legalize medical and recreational cannabis.

Medical Marketing & Media (MM&M) releases its annual list of top healthcare agencies, places Continuum Clinical at #59.

Joint Statement by Matthew L. Myers, President, Campaign for Tobacco-Free Kids; Harold P. Wimmer, National President and CEO, American Lung Association; Nancy Brown, CEO, American Heart Association

Conference Call and Webcast to Follow

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline for a supplemental New Drug Application (sNDA) for INVOKANA®

Company to Host Conference Call on Monday, July 16, 2018 at 5:30 a.m. PT / 8:30 a.m. ET

Torchmark Corporation will release Second Quarter 2018 earnings after the market closes on Wednesday, July 25, 2018.

Medical education plays an essential role in updating physicians and other health care professionals about new treatment options and advances in disease state understanding.

Health Canada is concerned by the decision of some federally licensed producers of cannabis for medical purposes to sponsor events, such as music festivals, and engage in other promotional activities, as reported recently by several Canadian media outlets.